Psychedelics and hypnosis: Commonalities and therapeutic implications
Lemercier, C. E., & Terhune, D. B. | Journal of Psychopharmacology | 25 June 2018
Dark Classics in Chemical Neuroscience: Mescaline
Cassels, B., & Sáez-Briones, P. | ACS chemical neuroscience | 8 June 2018
Psychiatry & the psychedelic drugs. Past, present & future.
Rucker, J. J., Iliff, J., & Nutt, D. J. | Neuropharmacology | 25 December 2017
Perceptions of the medicinal value of hallucinogenic drugs among college students
Wildberger, J. I., John, C. N., & Hallock, R. M. | Journal of Psychedelic Studies | 17 October 2017
Psychedelic Drugs in Biomedicine
Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R., Nichols, D. E., & Kalueff, A. V. | Trends in Pharmacological Sciences | 22 September 2017
Mystical mobilities and entheogenic Latin America
Giucci, G. | The Journal of Transport History | 14 September 2017
The hyperassociative mind: The psychedelic experience and Merleau-Ponty’s “wild being”
Szummer, C., Horváth, L., SzabÓ, A., Frecska, E., & OrzÓi, K. | Journal of Psychedelic Studies | 20 July 2017
Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways
López-Giménez, J. F., & González-Maeso, J. | Current Topics in Behavioral Neuroscience | 5 July 2017
Humanistic Psychology, Psychedelics, and the Transpersonal Vision
Grob, C. S., & Bossis, A. | Journal of Humanistic Psychology | 1 July 2017
Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness
Forstmann, M., & Sagioglou, C. | Journal of Psychopharmacology | 1 June 2017
Chemistry and Structure-Activity Relationships of Psychedelics
Nichols, D. E. | Current topics in behavioral neurosciences | 26 March 2017
Peyote as Commodity: An Examination of Market Actors and Access Mechanisms
Feeney, K. | Human Organization | 1 March 2017
Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging
dos Santos, R. G., Osório, F. L., Crippa, J. A. S., & Hallak, J. E. | Neuroscience & Biobehavioral Reviews | 31 October 2016
Classic Psychedelics and Rational Suicide in the Elderly: Exploring the Potential Utility of a Reemerging Treatment Paradigm
Hendricks, P. S., & Grob, C. S. | Rational Suicide in the Elderly | 29 October 2016
The Entheogen Reformation
Roberts, T. B. | Association for Transpersonal Psychology | 1 October 2016
Clinical Applications of Hallucinogens: A Review
Garcia-Romeu, A., Kersgaard, B., & Addy, P. H. | Experimental and clinical psychopharmacology | 1 July 2016
Anxiety Mescaline
Kyzar, E. J., Collins, C., Gaikwad, S., Green, J., Roth, A., Monnig, L., ... & Stewart, A. M.
Plant and Fungal Hallucinogens as Toxic and Therapeutic Agents
Carlini, E. A., & Maia, L. O. | 9 November 2015
Psychedelic medicine: A re-emerging therapeutic paradigm
Tupper, K. W., Wood, E., Yensen, R., & Johnson, M. W. | CMAJ: Canadian Medical Association journal= journal de l'Association medicale canadienne | 08 September 2015
Psychedelics and creativity: a review of the quantitative literature
Baggott, M. J. | PeerJ PrePrints | 30 June 2015
A Note on the Docking of some Hallucinogens to the 5-HT2A Receptor
Gómez-Jeria, J. S., & Robles-Navarro, A. | Journal of Computational Methods in Molecular Design | April 2015
Classic hallucinogens in the treatment of addictions
Bogenschutz, M. P., & Johnson, M. W. | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 14 March 2015
Psychedelics not linked to mental health problems or suicidal behavior: A population study
Johansen, P. Ø., & Krebs, T. S. | Journal of Psychopharmacology | 5 March 2015
What Can Neuroscience Tell Us About the Potential of Psychedelics in Healthcare?
Mackenzie, R. | Current Drug Abuse Reviews | 23 February 2015
Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
Majić, T., Schmidt, T. T., & Gallinat, J. | Journal of Psychopharmacology | 9 February 2015